You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動|貴州百靈大漲逾8%發佈多項研究成果涉及產品糖寧通絡
格隆匯 08-19 14:00
格隆匯8月19日丨貴州百靈(002424.SZ)大漲逾8%,報9.27元,成交1.46億元,總市值131億港元。

(行情來源:富途證券)
8月18日,貴州百靈研究成果發佈會在貴州安順召開。發佈會通報了糖寧通絡4年來的最新研究進展及兩篇論文在《科學》系列《科學進展》和《細胞通訊與信號》發表的情況,同時對糖寧通絡化學衍生物通過新靶點篩選的情況進行了總結。糖寧通絡是貴州百靈在糖尿病治療領域的重要佈局。
貴州百靈董事長姜偉在發佈會上表示,此次糖寧通絡研究成果和糖尿病治療新靶點的發現,將為糖尿病治療提供全新思路。後續,貴州百靈將繼續聯合國內頂尖科研機構、院所和頂級專家,進一步研究糖寧通絡及其化合物的作用特點和機制。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account